• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质组学分析癌症组织鉴定 IGF2R 为喉癌潜在的治疗靶点。

Proteomics analysis of cancer tissues identifies IGF2R as a potential therapeutic target in laryngeal carcinoma.

机构信息

Xuzhou Clinical School, Xuzhou Medical University, Xuzhou, China.

Department of Otolaryngology-Head and Neck Surgery, Xuzhou Central Hospital, Xuzhou, China.

出版信息

Front Endocrinol (Lausanne). 2022 Oct 10;13:1031210. doi: 10.3389/fendo.2022.1031210. eCollection 2022.

DOI:10.3389/fendo.2022.1031210
PMID:36299463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9592118/
Abstract

BACKGROUND

Laryngeal cancer (LC) is a prevalent head and neck malignancy; however, the essential pathophysiological mechanism underlying its tumorigenesis and progression remains elusive. Due to the perduring scarcity of effective targeted drugs for laryngeal cancer, insights into the disease's pathophysiological mechanisms would substantially impact the treatment landscape of laryngeal cancer.

METHODS

To ensure quality consistency, 10 tumor and 9 non-tumor samples underwent proteomic analysis on a single mass spectrometer using a label-free technique. Subsequently, gene expression variations between laryngeal squamous cell carcinoma and normal tissues were analyzed using The Cancer Genome Atlas (TCGA) database. Immunohistochemical expressions of insulin-like growth factor 2 receptor (IGF2R), fibronectin (FN), vimentin, and α-smooth muscle actin (SMA) in LC tissues and normal tissues were determined.

RESULTS

In the tumor group, significant variations were detected for 433 upregulated and 61 downregulated proteins. Moreover, the heatmap revealed that the expressions of RNA translation-related proteins and proteins involved in RNA metabolism, such as IGF2R, tenascin C (TNC), periostin (POSTN), proteasome 26S subunit ATPase 4 (PSMC4), serpin family A member 3 (SERPINA3), heat shock protein family B (small) member 6 (HSPB6), osteoglycin (OGN), chaperonin containing TCP1 subunit 6A (CCT6A), and chaperonin containing TCP1 subunit 6B (CCT6B), were prominently elevated in the tumor group. Nonsense-mediated RNA decay (NMD), RNA translation, and protein stability were significantly altered in LC tumors. IGF2R was remarkably upregulated in LC tumors. In the TCGA database, the IGF2R mRNA level was significantly upregulated in LSCC tissues. Additionally, IGF2R mRNA expression was lowest in clinical grade 1 samples, with no significant difference between grades 2 and 3. In LSCC patients, a significant positive correlation between IGF2R expression and the stromal score was detected using the ESTIMATE algorithm to estimate the immune score, stromal score, and tumor purity in the tumor microenvironment. Lastly, immunohistochemical analysis revealed that IGF2R is overexpressed in LC.

CONCLUSION

These results demonstrate the vital role of IGF2R in LC carcinogenesis and progression and may facilitate the identification of new therapeutic targets for the prevention and treatment of LC.

摘要

背景

喉癌(LC)是一种常见的头颈部恶性肿瘤;然而,其肿瘤发生和进展的基本病理生理机制仍难以捉摸。由于目前缺乏有效的喉癌靶向药物,因此深入了解疾病的病理生理机制将极大地影响喉癌的治疗格局。

方法

为确保质量一致性,对 10 个肿瘤和 9 个非肿瘤样本在单个质谱仪上使用无标记技术进行蛋白质组分析。随后,使用癌症基因组图谱(TCGA)数据库分析喉鳞状细胞癌和正常组织之间的基因表达差异。在 LC 组织和正常组织中,通过免疫组织化学方法检测胰岛素样生长因子 2 受体(IGF2R)、纤连蛋白(FN)、波形蛋白和α-平滑肌肌动蛋白(SMA)的表达。

结果

在肿瘤组中,检测到 433 个上调和 61 个下调蛋白的显著变化。此外,热图显示 IGF2R、tenascin C(TNC)、periostin(POSTN)、蛋白酶体 26S 亚基 ATPase 4(PSMC4)、丝氨酸蛋白酶家族 A 成员 3(SERPINA3)、热休克蛋白家族 B(小)成员 6(HSPB6)、骨连接蛋白(OGN)、含 TCP1 亚基的伴侣蛋白 6A(CCT6A)和含 TCP1 亚基的伴侣蛋白 6B(CCT6B)等与 RNA 翻译和 RNA 代谢相关的蛋白质的表达明显升高。在 LC 肿瘤中,非依赖性 RNA 衰变(NMD)、RNA 翻译和蛋白质稳定性显著改变。IGF2R 在 LC 肿瘤中明显上调。在 TCGA 数据库中,LSCC 组织中 IGF2R 的 mRNA 水平显著上调。此外,在临床分级 1 样本中 IGF2RmRNA 表达最低,2 级和 3 级之间无显著差异。在 LSCC 患者中,使用 ESTIMATE 算法估计肿瘤微环境中的免疫评分、基质评分和肿瘤纯度,发现 IGF2R 表达与基质评分之间存在显著正相关。最后,免疫组织化学分析显示 IGF2R 在 LC 中过度表达。

结论

这些结果表明 IGF2R 在 LC 癌发生和进展中起着重要作用,并可能有助于识别预防和治疗 LC 的新治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/bf8911382dca/fendo-13-1031210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/8a1d7457fff5/fendo-13-1031210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/be7bd14f81c6/fendo-13-1031210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/49a74d1904b7/fendo-13-1031210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/99c182232c21/fendo-13-1031210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/bf8911382dca/fendo-13-1031210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/8a1d7457fff5/fendo-13-1031210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/be7bd14f81c6/fendo-13-1031210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/49a74d1904b7/fendo-13-1031210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/99c182232c21/fendo-13-1031210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e046/9592118/bf8911382dca/fendo-13-1031210-g005.jpg

相似文献

1
Proteomics analysis of cancer tissues identifies IGF2R as a potential therapeutic target in laryngeal carcinoma.蛋白质组学分析癌症组织鉴定 IGF2R 为喉癌潜在的治疗靶点。
Front Endocrinol (Lausanne). 2022 Oct 10;13:1031210. doi: 10.3389/fendo.2022.1031210. eCollection 2022.
2
Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.磷酸丙糖异构酶 1 可能是喉鳞状细胞癌的风险预测因子:一项整合了 bulk RNA、单细胞 RNA 和蛋白免疫组化的多中心研究。
Eur J Med Res. 2023 Dec 15;28(1):591. doi: 10.1186/s40001-023-01568-8.
3
LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.LMX1B mRNA 表达及其基因体 CpG 甲基化是喉鳞状细胞癌有价值的预后生物标志物。
Biomed Pharmacother. 2019 Sep;117:109174. doi: 10.1016/j.biopha.2019.109174. Epub 2019 Jul 8.
4
Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.肿瘤坏死因子超家族成员13是一种用于诊断和预后的新型生物标志物,并促进喉鳞状细胞癌中的癌细胞增殖。
Tumour Biol. 2016 Feb;37(2):2635-45. doi: 10.1007/s13277-015-4016-8. Epub 2015 Sep 23.
5
HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.HOX基因:喉鳞状细胞癌进展的潜在候选因素。
Tumour Biol. 2016 Nov;37(11):15087-15096. doi: 10.1007/s13277-016-5356-8. Epub 2016 Sep 22.
6
Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.喉鳞状细胞癌中IGF2和H19印记缺失、IGF2R和CTCF杂合性缺失以及幽门螺杆菌感染
J Mol Med (Berl). 2008 Sep;86(9):1057-66. doi: 10.1007/s00109-008-0369-4. Epub 2008 Jul 5.
7
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.SLC7A11,半胱氨酸/谷氨酸转运体的一个组成部分,是喉鳞状细胞癌诊断和预后的一个新的生物标志物。
Oncol Rep. 2017 Nov;38(5):3019-3029. doi: 10.3892/or.2017.5976. Epub 2017 Sep 20.
8
Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.整合 miRNA 和 mRNA 表达分析揭示喉鳞状细胞癌患者的药物靶点。
Oral Oncol. 2019 Jun;93:76-84. doi: 10.1016/j.oraloncology.2019.04.018. Epub 2019 Apr 29.
9
Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples - a Pilot Study.基于福尔马林固定石蜡包埋组织样本的喉/下咽鳞状细胞癌的无标记半定量液相色谱-串联质谱蛋白质组学分析 - 一项初步研究。
Pathol Oncol Res. 2020 Oct;26(4):2801-2807. doi: 10.1007/s12253-020-00849-5. Epub 2020 Jun 21.
10
The role of α-smooth muscle actin in confirming the microinvasion of laryngeal squamous cell carcinoma.α-平滑肌肌动蛋白在确认喉鳞状细胞癌微浸润中的作用。
Ann Diagn Pathol. 2021 Oct;54:151804. doi: 10.1016/j.anndiagpath.2021.151804. Epub 2021 Aug 4.

引用本文的文献

1
Potential therapeutic targets for colorectal cancer and its subsites: evidence from the proteome-wide Mendelian randomization analyses.结直肠癌及其亚部位的潜在治疗靶点:来自全蛋白质组孟德尔随机化分析的证据
Transl Cancer Res. 2025 Jan 31;14(1):486-496. doi: 10.21037/tcr-24-1503. Epub 2025 Jan 20.
2
Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.从遗传变异角度揭示子宫内膜癌亚型的潜在药物靶点。
Sci Rep. 2024 Nov 15;14(1):28180. doi: 10.1038/s41598-024-78689-5.
3
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies.

本文引用的文献

1
Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment.血清蛋白质组学在头颈部癌症患者中的应用:外周血对治疗的免疫反应。
Int J Mol Sci. 2022 Jun 4;23(11):6304. doi: 10.3390/ijms23116304.
2
The miR-4306/IGF2R axis modulates the lung adenocarcinoma response to irradiation and .miR-4306/IGF2R轴调节肺腺癌对放疗的反应 以及 。 (你提供的原文结尾不完整,我只能按照现有内容准确翻译。)
Transl Lung Cancer Res. 2021 Dec;10(12):4494-4510. doi: 10.21037/tlcr-21-890.
3
Trop2 binding IGF2R induces gefitinib resistance in NSCLC by remodeling the tumor microenvironment.
口腔鳞状细胞癌微环境中的生物标志物鉴定:蛋白质组学研究的系统评价。
Int J Mol Sci. 2024 Aug 16;25(16):8929. doi: 10.3390/ijms25168929.
4
SIRT5 suppresses the trophoblast cell proliferation, invasion, and migration to promote preeclampsia via desuccinylating HOXB3.SIRT5 通过去琥珀酰化 HOXB3 抑制滋养细胞增殖、侵袭和迁移,从而促进子痫前期的发生。
J Assist Reprod Genet. 2024 Oct;41(10):2759-2770. doi: 10.1007/s10815-024-03223-5. Epub 2024 Aug 15.
5
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer.乳腺癌中新型转移相关免疫基因特征的鉴定与验证
Breast Cancer (Dove Med Press). 2024 Apr 12;16:199-219. doi: 10.2147/BCTT.S448642. eCollection 2024.
6
Investigation of the Proteasome 26S Subunit, ATPase Family Genes as Potential Prognostic Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.蛋白酶体26S亚基ATP酶家族基因作为肝细胞癌潜在预后生物标志物和治疗靶点的研究
Cancer Manag Res. 2024 Feb 13;16:95-111. doi: 10.2147/CMAR.S449488. eCollection 2024.
7
The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer.19S ATP酶蛋白酶体亚基在急性髓系白血病及其他癌症中的预后价值
Front Med (Lausanne). 2023 Jul 12;10:1209425. doi: 10.3389/fmed.2023.1209425. eCollection 2023.
Trop2与IGF2R结合通过重塑肿瘤微环境诱导非小细胞肺癌对吉非替尼耐药。
J Cancer. 2021 Jul 3;12(17):5310-5319. doi: 10.7150/jca.57711. eCollection 2021.
4
Development of a new EGFR antibody antagonist which exhibits potential biological effects against laryngeal cancer.一种新型表皮生长因子受体(EGFR)抗体拮抗剂的研发,该拮抗剂对喉癌显示出潜在生物学效应。
Ann Transl Med. 2021 Jun;9(12):964. doi: 10.21037/atm-21-1839.
5
Cancer of the Larynx and Hypopharynx.喉和下咽癌。
Hematol Oncol Clin North Am. 2021 Oct;35(5):933-947. doi: 10.1016/j.hoc.2021.05.005. Epub 2021 Jul 14.
6
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.RBM15 通过 IGF2BP3 依赖性调节 TMBIM6 的稳定性促进喉鳞状细胞癌的进展。
J Exp Clin Cancer Res. 2021 Feb 26;40(1):80. doi: 10.1186/s13046-021-01871-4.
7
Anti-EGFR treatment effects on laryngeal cancer stem cells.抗表皮生长因子受体治疗对喉癌干细胞的作用。
Am J Transl Res. 2021 Jan 15;13(1):143-155. eCollection 2021.
8
IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages.IGF2R启动的质子重新通道化决定了巨噬细胞中的抗炎特性。
Sci Adv. 2020 Nov 25;6(48). doi: 10.1126/sciadv.abb7389. Print 2020 Nov.
9
Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.下咽及喉鳞状细胞癌的蛋白质组学分析揭示了生存率的差异。
Sci Rep. 2020 Nov 10;10(1):19459. doi: 10.1038/s41598-020-76626-w.
10
Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples - a Pilot Study.基于福尔马林固定石蜡包埋组织样本的喉/下咽鳞状细胞癌的无标记半定量液相色谱-串联质谱蛋白质组学分析 - 一项初步研究。
Pathol Oncol Res. 2020 Oct;26(4):2801-2807. doi: 10.1007/s12253-020-00849-5. Epub 2020 Jun 21.